Current management of the hemophilic child: A demanding interlocutor. Quality of life and adequate cost-efficacy analysis

Paola Giordano, Giuseppe Lassandro, Michele Valente, Angelo Claudio Molinari, Paola Ieranò, Antonio Coppola

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Hemophilias are the most known inherited bleeding disorders. The challenges in the management of hemophilic children are different from those in adults: prophylaxis regimen removed the hallmark of crippling disease with lifelong disabilities; individualized regimens are being implemented in order to overcome venous access problems. Presently, at least in high-income countries, advances in treatment of hemophilia resulted in continuous improvement of the patients' quality of life and life expectancy. Inhibitors remain the most severe complication of hemophilia therapy. The treatment' compliance is the key to achieve a successful management. The patient, his family, the medical and psychological team are the players of a comprehensive care system. The current management of hemophilic children is the example of huge resource investments enabling long-term benefits in particular quality of life as a primary objective of the healthcare process.

Original languageEnglish
Pages (from-to)687-702
Number of pages16
JournalPediatric Hematology and Oncology
Volume31
Issue number8
DOIs
Publication statusPublished - Nov 1 2014

Fingerprint

Quality of Life
Hemophilia A
Costs and Cost Analysis
Life Expectancy
Compliance
Primary Health Care
Therapeutics
Hemorrhage
Psychology

Keywords

  • Children
  • Cost-analysis
  • Health-related quality of life
  • Hemophilia
  • Prophylaxis
  • Replacement treatment

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology
  • Medicine(all)

Cite this

Current management of the hemophilic child : A demanding interlocutor. Quality of life and adequate cost-efficacy analysis. / Giordano, Paola; Lassandro, Giuseppe; Valente, Michele; Molinari, Angelo Claudio; Ieranò, Paola; Coppola, Antonio.

In: Pediatric Hematology and Oncology, Vol. 31, No. 8, 01.11.2014, p. 687-702.

Research output: Contribution to journalArticle

Giordano, Paola ; Lassandro, Giuseppe ; Valente, Michele ; Molinari, Angelo Claudio ; Ieranò, Paola ; Coppola, Antonio. / Current management of the hemophilic child : A demanding interlocutor. Quality of life and adequate cost-efficacy analysis. In: Pediatric Hematology and Oncology. 2014 ; Vol. 31, No. 8. pp. 687-702.
@article{24c31f6738844450a4a866dac3bff0b1,
title = "Current management of the hemophilic child: A demanding interlocutor. Quality of life and adequate cost-efficacy analysis",
abstract = "Hemophilias are the most known inherited bleeding disorders. The challenges in the management of hemophilic children are different from those in adults: prophylaxis regimen removed the hallmark of crippling disease with lifelong disabilities; individualized regimens are being implemented in order to overcome venous access problems. Presently, at least in high-income countries, advances in treatment of hemophilia resulted in continuous improvement of the patients' quality of life and life expectancy. Inhibitors remain the most severe complication of hemophilia therapy. The treatment' compliance is the key to achieve a successful management. The patient, his family, the medical and psychological team are the players of a comprehensive care system. The current management of hemophilic children is the example of huge resource investments enabling long-term benefits in particular quality of life as a primary objective of the healthcare process.",
keywords = "Children, Cost-analysis, Health-related quality of life, Hemophilia, Prophylaxis, Replacement treatment",
author = "Paola Giordano and Giuseppe Lassandro and Michele Valente and Molinari, {Angelo Claudio} and Paola Ieran{\`o} and Antonio Coppola",
year = "2014",
month = "11",
day = "1",
doi = "10.3109/08880018.2014.930768",
language = "English",
volume = "31",
pages = "687--702",
journal = "Pediatric Hematology and Oncology",
issn = "0888-0018",
publisher = "Informa Healthcare",
number = "8",

}

TY - JOUR

T1 - Current management of the hemophilic child

T2 - A demanding interlocutor. Quality of life and adequate cost-efficacy analysis

AU - Giordano, Paola

AU - Lassandro, Giuseppe

AU - Valente, Michele

AU - Molinari, Angelo Claudio

AU - Ieranò, Paola

AU - Coppola, Antonio

PY - 2014/11/1

Y1 - 2014/11/1

N2 - Hemophilias are the most known inherited bleeding disorders. The challenges in the management of hemophilic children are different from those in adults: prophylaxis regimen removed the hallmark of crippling disease with lifelong disabilities; individualized regimens are being implemented in order to overcome venous access problems. Presently, at least in high-income countries, advances in treatment of hemophilia resulted in continuous improvement of the patients' quality of life and life expectancy. Inhibitors remain the most severe complication of hemophilia therapy. The treatment' compliance is the key to achieve a successful management. The patient, his family, the medical and psychological team are the players of a comprehensive care system. The current management of hemophilic children is the example of huge resource investments enabling long-term benefits in particular quality of life as a primary objective of the healthcare process.

AB - Hemophilias are the most known inherited bleeding disorders. The challenges in the management of hemophilic children are different from those in adults: prophylaxis regimen removed the hallmark of crippling disease with lifelong disabilities; individualized regimens are being implemented in order to overcome venous access problems. Presently, at least in high-income countries, advances in treatment of hemophilia resulted in continuous improvement of the patients' quality of life and life expectancy. Inhibitors remain the most severe complication of hemophilia therapy. The treatment' compliance is the key to achieve a successful management. The patient, his family, the medical and psychological team are the players of a comprehensive care system. The current management of hemophilic children is the example of huge resource investments enabling long-term benefits in particular quality of life as a primary objective of the healthcare process.

KW - Children

KW - Cost-analysis

KW - Health-related quality of life

KW - Hemophilia

KW - Prophylaxis

KW - Replacement treatment

UR - http://www.scopus.com/inward/record.url?scp=84909972146&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84909972146&partnerID=8YFLogxK

U2 - 10.3109/08880018.2014.930768

DO - 10.3109/08880018.2014.930768

M3 - Article

C2 - 25006797

AN - SCOPUS:84909972146

VL - 31

SP - 687

EP - 702

JO - Pediatric Hematology and Oncology

JF - Pediatric Hematology and Oncology

SN - 0888-0018

IS - 8

ER -